| __timestamp | Bristol-Myers Squibb Company | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 15879000000 | 9757000 |
| Thursday, January 1, 2015 | 16560000000 | 1253000 |
| Friday, January 1, 2016 | 19427000000 | 5421000 |
| Sunday, January 1, 2017 | 20776000000 | 154584000 |
| Monday, January 1, 2018 | 22561000000 | 301034000 |
| Tuesday, January 1, 2019 | 26145000000 | 380833000 |
| Wednesday, January 1, 2020 | 42518000000 | 540099000 |
| Friday, January 1, 2021 | 46385000000 | 701887000 |
| Saturday, January 1, 2022 | 46159000000 | 933013000 |
| Sunday, January 1, 2023 | 45006000000 | 1243336000 |
| Monday, January 1, 2024 | 48300000000 |
Cracking the code
In the competitive landscape of the pharmaceutical industry, revenue growth is a key indicator of success. From 2014 to 2023, Bristol-Myers Squibb Company has consistently outperformed Sarepta Therapeutics, Inc. in terms of annual revenue. Bristol-Myers Squibb's revenue surged by approximately 184% over this period, peaking in 2021 with a remarkable $46.4 billion. In contrast, Sarepta Therapeutics, while showing impressive growth, increased its revenue by over 12,600%, reaching $1.24 billion in 2023. This stark difference highlights Bristol-Myers Squibb's dominance in the market, driven by its diverse portfolio and strategic acquisitions. Meanwhile, Sarepta's focus on niche markets, such as gene therapy, has fueled its rapid growth, albeit from a smaller base. As the pharmaceutical landscape evolves, these companies' strategies will continue to shape their financial trajectories.
Who Generates More Revenue? AbbVie Inc. or Bristol-Myers Squibb Company
Revenue Insights: Merck & Co., Inc. and Bristol-Myers Squibb Company Performance Compared
Bristol-Myers Squibb Company and Gilead Sciences, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Bristol-Myers Squibb Company vs United Therapeutics Corporation
Breaking Down Revenue Trends: Bristol-Myers Squibb Company vs Exelixis, Inc.
Bristol-Myers Squibb Company and Jazz Pharmaceuticals plc: A Comprehensive Revenue Analysis
Bristol-Myers Squibb Company vs Telix Pharmaceuticals Limited: Annual Revenue Growth Compared
Bristol-Myers Squibb Company vs HUTCHMED (China) Limited: Examining Key Revenue Metrics
Bristol-Myers Squibb Company and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Bristol-Myers Squibb Company vs Taro Pharmaceutical Industries Ltd.
Sarepta Therapeutics, Inc. or Alkermes plc: Who Leads in Yearly Revenue?
Revenue Showdown: Sarepta Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.